Reviewed by Christian Espinosa, MBA, CISSP · Founder & CEO
Published November 2025 · Last reviewed May 2026
The Med Device Cyber Podcast · with Kevin Saem · November 30, 2025 This episode of The Med Device Cyber Podcast features Kevin Saem from Zapirus, who discusses how market intelligence is revolutionizing the MedTech industry. Saem highlights the historical gap in regulatory and sales sophistication between MedTech and other life sciences, traditionally lagging by about five years. He introduces Zapirus, a SaaS platform designed to centralize business development research and automate lead qualification for MedTech service providers through machine learning and AI. The conversation emphasizes the increasing importance of cybersecurity in MedTech, driven by the emergence of connected devices, software as a medical device (SaMD), and large language models. The hosts and Saem discuss how proactively addressing cybersecurity, akin to early human factors engineering, is crucial for mitigating risks, avoiding costly delays in FDA approvals, and attracting investment. They reference notable cases like the Aluminina False Claims Act settlement and a concerning AI therapy incident to underscore the tangible consequences of neglecting robust security measures. The episode concludes by stressing the need for MedTech companies to adopt a proactive, process-driven approach to cybersecurity and market intelligence to ensure sustainable growth and investor confidence in an increasingly competitive and regulated landscape.
Key Takeaways
- MedTech has historically lagged behind other life sciences in regulatory and sales sophistication, but market intelligence tools are bridging this gap.
- Proactive cybersecurity measures are essential for MedTech companies to secure FDA approvals, attract investment, and prevent critical incidents.
- The increasing complexity of connected devices, SaMD, and AI in MedTech necessitates a 'security-first' approach to product development.
- Companies need to move beyond word-of-mouth growth by implementing robust commercial strategies and utilizing market intelligence for sustainable scaling.
- Neglecting cybersecurity can lead to severe consequences, including significant FDA delays, financial penalties, and even patient harm.
- Adopting a systematic and repeatable process for both cybersecurity and market intelligence is crucial for long-term business success and scalability.
Listen on mdcpodcast.com · Watch on YouTube
Listen to this episode
Want help applying this to your own device program?
Blue Goat Cyber is a specialist medical device cybersecurity firm: 250+ FDA submissions, zero rejections. If anything in this conversation hit close to home, book a 30-minute strategy session - no cost, no obligation.